CTRI/2012/05/002658已完成3 期
CENTCHROMAN VS TAMOXIFEN FOR REGRESSION OF MASTALGIA: A DOUBLE BLIND RANDOMIZED CONTROLLED TRIA
niversity College of Medical Sciences University of Delhi Delhi0 个研究点目标入组 58 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 58
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. All patients having mastalgia with VAS score above 3/10
- •2. Duration of mastalgia > 3 months
排除标准
- •1.Past history of breast carcinoma or family history of breast carcinoma.
- •2.Acute inflammatory breast conditions
- •3.Discrete breast lumps
- •4.Patients with oligomenorrhoea, irregular bleeding, ovarian cysts or cervical hyperplasia.
- •5.Lactation period â?? first 6 months
- •6.Pregnant or planning to conceive
研究者
相似试验
招募中
Unknown
Centchroman vs tamoxifen in patients with breast paiCTRI/2023/11/059992on-funded
Unknown
3 期
A clinical trial to study the effects of two drugs, Centchroman versus Tamoxifen in patients with breast pain and non-cancerous breast lumps.CTRI/2016/05/006905Intra Mural Grant from All India Institute of Medical Sciences New Delhi200
已完成
4 期
Comparing effectiveness of Centchroman and Tamoxifen in mastalgia: a randomised control trialCTRI/2021/01/030206AIIMS Bhubaneswar56
已完成
不适用
STUDY OF TAMOXIFEN AND EXEMESTANE MORE GNRH ANALOGUE AS ADJUVANT THERAPY FOR PREMENOPAUSIC WOMEN WITH BREAST CANCER WITH ENDOCRINE RESPONSE-C50 Malignant neoplasm of breastMalignant neoplasm of breastC50PER-069-03INTERNATIONAL BREAST CANCER STUDY GROUP - IBCSG,
招募中
不适用
T&T trial: adding Testosterone to Tamoxifen in male breast cancer patientsmale breast cancer10006291NL-OMON51371niversitair Medisch Centrum Groningen6